Federal grants to Microbiotix, Inc.
Microbiotix, Inc. in Worcester, Massachusetts received $15.0 million in federal grants from fiscal 2021 to 2025, across 19 awards. Its largest program was Allergy and Infectious Diseases Research, with $11.5 million. In fiscal 2025 it was awarded $3.6 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$15.0 million
- Awards19
- Awarded in FY 2025$3.6 million
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 10 | $7.0 million |
| FY 2022 | 4 | $2.3 million |
| FY 2023 | 3 | $1.6 million |
| FY 2024 | 2 | $586,708 |
| FY 2025 | 6 | $3.6 million |
Programs that fund Microbiotix, Inc.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 15 | $11.5 million |
| Vision Research | 3 | $2.4 million |
| Military Medical Research and Development | 1 | $1.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 18 | $14.0 million |
| Department of Defense | 1 | $1.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Screening for raav transduction enhancers - abstract recombinant adeno-associated virus (RAAV) is an established vector for gene therapy and vaccines with the potential to radically change the face of modern healthcare. Although extremely promising, with two examples already approved for clinical us | Allergy and Infectious Diseases Research | February 3, 2021 | $3.0 million |
| Development of filociclovir for the treatment of ocular adenoviral infections and keratoconjunctivitis - project summary/abstract the long-term goal of this project, to develop filociclovir (FCV) for the safe and effective treatment of human ocular adenovirus (ADV) infections, especially adv-related | Vision Research | May 25, 2021 | $1.5 million |
| Oxadiazole inhibitors of non-stop ribosome rescue to treat mdr neisseria gonorrhoeae | Allergy and Infectious Diseases Research | July 22, 2021 | $1.1 million |
| Oxadiazole inhibitors of bacterial nonstop ribosome rescue for treating tick-borne diseases lyme and tularemia in military personnel, veterans and civilians | Military Medical Research and Development | July 29, 2025 | $1.0 million |
| Optimization of novel pyranopyridine efflux pump inhibitors | Allergy and Infectious Diseases Research | August 26, 2021 | $1.0 million |
| Novel spectinamide antibiotics for the treatment of mdr/xdr tuberculosis | Allergy and Infectious Diseases Research | August 17, 2021 | $996,798 |
| Novel plasmodial surface anion channel inhibitors as antimalarial drugs | Allergy and Infectious Diseases Research | December 15, 2020 | $982,478 |
| Discovery of bunyaviral endonuclease inhibitors for anti viral - abstract segmented negative-sense, single-stranded rna viruses (SNSVS), which include bunyaviruses, are causative agents of human diseases. Rift valley fever virus (RVFV), a mosquito-borne virus causing hemorrhagic fever in humans, is | Allergy and Infectious Diseases Research | May 16, 2025 | $977,449 |
| Translational studies to advance filociclovir to ind submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitis - project summary/abstract the long-term goal of this project, to develop filociclovir (FCV) for the safe and effective treatment of human adenovirus (HADV) o | Vision Research | December 16, 2024 | $674,963 |
| Proof of concept experiments for T3SS inhibitors against burn wound infections - abstract the overall goal of this proposal is to develop a novel therapy for the treatment of burn wound infections caused by the opportunistic gram-negative pathogen pseudomonas aeruginosa (PAER), a leading cause of bu | Allergy and Infectious Diseases Research | April 12, 2024 | $600,000 |
Questions people ask
How much federal grant money does Microbiotix, Inc. get?
$15.0 million in 19 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Microbiotix, Inc. the most?
The Department of Health and Human Services, with $14.0 million in 18 awards. The Department of Defense follow.
What is Microbiotix, Inc.'s largest federal grant?
$3.0 million under Allergy and Infectious Diseases Research, with its first action in the period on February 3, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Microbiotix, Inc.?
Its largest are Allergy and Infectious Diseases Research, Vision Research and Military Medical Research and Development.
Other grant recipients in Worcester
- University of Massachusetts Medical School
- Worcester Polytechnic Institute
- Worcester Housing Authority
- Worcester Regional Transit Authority
- City of Worcester
- Veterans Inc
- Family Health Center of Worcester Inc
- Edward M Kennedy Community Health Center, Inc
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts